Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020112814 - DEVICES, SYSTEMS, AND METHODS TO MONITOR SUBJECT COMPLIANCE WITH A PHARMACEUTICAL TREATMENT REGIMEN

Publication Number WO/2020/112814
Publication Date 04.06.2020
International Application No. PCT/US2019/063307
International Filing Date 26.11.2019
IPC
A61B 5/145 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
145Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
A61B 5/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
CPC
A61B 5/0004
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Detecting, measuring or recording for diagnostic purposes
0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
0004characterised by the type of physiological signal transmitted
A61B 5/0022
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Detecting, measuring or recording for diagnostic purposes
0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
0015characterised by features of the telemetry system
0022Monitoring a patient using a global network, e.g. telephone networks, internet
A61B 5/0071
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Detecting, measuring or recording for diagnostic purposes
0059using light, e.g. diagnosis by transillumination, diascopy, fluorescence
0071by measuring fluorescence emission
A61B 5/01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Detecting, measuring or recording for diagnostic purposes
01Measuring temperature of body parts; ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
A61B 5/0205
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Detecting, measuring or recording for diagnostic purposes
02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
A61B 5/021
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Detecting, measuring or recording for diagnostic purposes
02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
021Measuring pressure in heart or blood vessels
Applicants
  • SAKAYA, Jaqueline Mbwille [US]/[US]
Inventors
  • SAKAYA, Jaqueline Mbwille
Agents
  • PISANO, Anthony
  • BASU, Palash
  • BONNER, Anthony F.
  • BONNER, Brian M.
  • BRENTLINGER, Nicolas A.
  • CHOI, Yongsok
  • EARLE, Ashley J.
  • ELSWICK, Christopher W.
  • INGLE, Corey J.
  • JIVIDEN, William A.
  • KALTER, Alexander J.
  • LAHMANN, Bethany R.
  • LIVINGSTON, Jennifer L.
  • MOLLOY, Matthew
  • NEIHEISEL, Craig E.
  • OBERHAUS, Geoffrey L.
  • PATSARIKAS, George A.
  • RERICHA, Nicholaus R.
  • SHIN, Miyoung
  • SIGURDSON, Nicole M.
  • SINGH, Ritu
  • TENT, Brian A.
  • WATHEN, Douglas L.
  • WISECUP, Bryan C.
  • WUENNENBERG, Gregory T.
  • ZHAO, Qiong J.
Priority Data
62/772,35028.11.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) DEVICES, SYSTEMS, AND METHODS TO MONITOR SUBJECT COMPLIANCE WITH A PHARMACEUTICAL TREATMENT REGIMEN
(FR) DISPOSITIFS, SYSTÈMES, ET PROCÉDÉS DE SURVEILLANCE DU RESPECT D’UN RÉGIME DE TRAITEMENT PHARMACEUTIQUE
Abstract
(EN)
Monitoring devices, systems including the same, and methods of monitoring subject compliance are described herein. A method to monitor compliance with a pharmaceutical treatment regimen includes obtaining, via an autosampler of a wearable medical device, a biological sample, the wearable medical device including the autosampler in fluid communication with the analyte detector. The method further includes determining a concentration of an analyte in the biological sample, which correlates with a probability that the subject received a bolus of the pharmaceutical within a period of time prior to obtaining the biological sample. The method further includes determining whether the concentration of the analyte suggests that the subject received the bolus of the pharmaceutical within the period of time and electronically transmitting a message indicating that the concentration suggests that the subject either received or did not receive the bolus of the pharmaceutical within the period of time.
(FR)
La présente invention concerne des dispositifs de surveillance, des systèmes les comprenant, et des procédés de surveillance du respect par le sujet. Un procédé de surveillance du respect d’un régime de traitement pharmaceutique comprend l’obtention, par l’intermédiaire d’un échantillonneur automatique d’un dispositif médical portable, d’un échantillon biologique, le dispositif médical portable comprenant l’échantillonneur automatique en communication fluidique avec le détecteur d’analyte. Le procédé comprend en outre la détermination d’une concentration d’un analyte dans l’échantillon biologique, qui se trouve en corrélation avec une probabilité que le sujet ait reçu un bolus du produit pharmaceutique à l’intérieur d’une période de temps avant d’obtenir l’échantillon biologique. Le procédé comprend en outre la détermination du fait que la concentration de l’analyte suggère que le sujet a reçu le bolus du produit pharmaceutique dans la période de temps et transmet électroniquement un message indiquant que la concentration suggère que le sujet soit a reçu soit n’a pas reçu le bolus du produit pharmaceutique dans la période de temps.
Latest bibliographic data on file with the International Bureau